Large-scale testing (Phase 3)Not Yet RecruitingNCT07239271
What this trial is testing
Phase III Clinical Study and Translational Research on Adaptive Neoadjuvant Therapy of De-escalation and Escalation for HER2-Positive Breast Cancer Based on Multi-Omics Response Evaluation Model
Who this might be right for
Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2,000